Re: Bicakli et al. Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer. J Oncol Pharm Pract, published online September 2014. DOI: 10.1177/1078155214551315
Source: Journal of Oncology Pharmacy Practice - Category: Cancer & Oncology Authors: Agilli, M., Aydin, F. N. Tags: Letters to the Editor Source Type: research